CS274502B2 - Method of glutaramide's derivatives' s-enantiomers production - Google Patents
Method of glutaramide's derivatives' s-enantiomers production Download PDFInfo
- Publication number
- CS274502B2 CS274502B2 CS296589A CS296589A CS274502B2 CS 274502 B2 CS274502 B2 CS 274502B2 CS 296589 A CS296589 A CS 296589A CS 296589 A CS296589 A CS 296589A CS 274502 B2 CS274502 B2 CS 274502B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- formula
- hydrogen
- cleaved
- indanyl
- give
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888811873A GB8811873D0 (en) | 1988-05-19 | 1988-05-19 | Therapeutic agents |
Publications (2)
Publication Number | Publication Date |
---|---|
CS296589A2 CS296589A2 (en) | 1990-09-12 |
CS274502B2 true CS274502B2 (en) | 1991-04-11 |
Family
ID=10637176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS296589A CS274502B2 (en) | 1988-05-19 | 1989-05-17 | Method of glutaramide's derivatives' s-enantiomers production |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP0342850B1 (xx) |
JP (1) | JPH072699B2 (xx) |
KR (1) | KR920000561B1 (xx) |
CN (1) | CN1015361B (xx) |
AT (1) | ATE76399T1 (xx) |
AU (1) | AU602813B2 (xx) |
CA (1) | CA1331197C (xx) |
CS (1) | CS274502B2 (xx) |
DD (1) | DD283772A5 (xx) |
DE (1) | DE68901582D1 (xx) |
DK (1) | DK172032B1 (xx) |
EG (1) | EG19007A (xx) |
ES (1) | ES2037418T3 (xx) |
FI (1) | FI93541C (xx) |
GB (1) | GB8811873D0 (xx) |
GR (1) | GR3004968T3 (xx) |
HU (1) | HU205067B (xx) |
IE (1) | IE60724B1 (xx) |
IL (1) | IL90267A (xx) |
MX (1) | MX16067A (xx) |
MY (1) | MY104735A (xx) |
NO (1) | NO173647C (xx) |
NZ (1) | NZ229186A (xx) |
PH (1) | PH26740A (xx) |
PL (1) | PL154813B1 (xx) |
PT (1) | PT90584B (xx) |
SU (1) | SU1766251A3 (xx) |
YU (1) | YU47973B (xx) |
ZA (1) | ZA893696B (xx) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8812597D0 (en) * | 1988-05-27 | 1988-06-29 | Pfizer Ltd | Therapeutic agents |
GB8820844D0 (en) * | 1988-09-05 | 1988-10-05 | Pfizer Ltd | Therapeutic agents |
GB9000725D0 (en) * | 1990-01-12 | 1990-03-14 | Pfizer Ltd | Therapeutic agents |
DK0644176T3 (da) * | 1993-09-22 | 1996-02-26 | Pfizer Ltd | Hydrogenering |
US7468390B2 (en) | 2002-01-17 | 2008-12-23 | Novartis Ag | Methods of treatment and pharmaceutical composition |
AR057882A1 (es) | 2005-11-09 | 2007-12-26 | Novartis Ag | Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra |
US8993631B2 (en) | 2010-11-16 | 2015-03-31 | Novartis Ag | Method of treating contrast-induced nephropathy |
WO2014029848A1 (en) | 2012-08-24 | 2014-02-27 | Novartis Ag | Nep inhibitors for treating diseases characterized by atrial enlargement or remodeling |
WO2017033128A1 (en) | 2015-08-25 | 2017-03-02 | Novartis Ag | Biphenyl-substitued 4-amino-butyric acid derivatives and their use in the synthesis of nep inhibitors |
US20180311241A1 (en) | 2015-10-29 | 2018-11-01 | Cadila Healthcare Limited | Pharmaceutical synergistic combination |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR880007441A (ko) * | 1986-12-11 | 1988-08-27 | 알렌 제이.스피겔 | 스피로-치환된 글루타르아미드 이뇨제 |
-
1988
- 1988-05-19 GB GB888811873A patent/GB8811873D0/en active Pending
-
1989
- 1989-05-09 DE DE8989304698T patent/DE68901582D1/de not_active Expired - Fee Related
- 1989-05-09 AT AT89304698T patent/ATE76399T1/de not_active IP Right Cessation
- 1989-05-09 EP EP89304698A patent/EP0342850B1/en not_active Expired - Lifetime
- 1989-05-09 ES ES198989304698T patent/ES2037418T3/es not_active Expired - Lifetime
- 1989-05-11 IL IL90267A patent/IL90267A/xx not_active IP Right Cessation
- 1989-05-16 MY MYPI89000654A patent/MY104735A/en unknown
- 1989-05-17 ZA ZA893696A patent/ZA893696B/xx unknown
- 1989-05-17 CA CA000599911A patent/CA1331197C/en not_active Expired - Fee Related
- 1989-05-17 CS CS296589A patent/CS274502B2/cs not_active IP Right Cessation
- 1989-05-17 MX MX1606789A patent/MX16067A/es unknown
- 1989-05-17 PL PL1989279491A patent/PL154813B1/pl unknown
- 1989-05-17 PT PT90584A patent/PT90584B/pt not_active IP Right Cessation
- 1989-05-17 HU HU892460A patent/HU205067B/hu not_active IP Right Cessation
- 1989-05-17 SU SU4614002A patent/SU1766251A3/ru active
- 1989-05-17 DD DD89328675A patent/DD283772A5/de not_active IP Right Cessation
- 1989-05-18 FI FI892386A patent/FI93541C/fi not_active IP Right Cessation
- 1989-05-18 AU AU34904/89A patent/AU602813B2/en not_active Ceased
- 1989-05-18 IE IE161389A patent/IE60724B1/en not_active IP Right Cessation
- 1989-05-18 NZ NZ229186A patent/NZ229186A/xx unknown
- 1989-05-18 NO NO892002A patent/NO173647C/no not_active IP Right Cessation
- 1989-05-18 JP JP1125479A patent/JPH072699B2/ja not_active Expired - Fee Related
- 1989-05-18 DK DK240889A patent/DK172032B1/da not_active IP Right Cessation
- 1989-05-18 YU YU102289A patent/YU47973B/sh unknown
- 1989-05-19 KR KR1019890006691A patent/KR920000561B1/ko not_active IP Right Cessation
- 1989-05-19 CN CN89103437A patent/CN1015361B/zh not_active Expired
- 1989-05-21 EG EG25089A patent/EG19007A/xx active
- 1989-06-12 PH PH38643A patent/PH26740A/en unknown
-
1992
- 1992-06-18 GR GR920401302T patent/GR3004968T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4153803A (en) | Cholesterol-lowering phenoxyalkanoic acid esters | |
US4562263A (en) | Process for producing 3-(3,4-dihydroxyphenyl) serine | |
CS274502B2 (en) | Method of glutaramide's derivatives' s-enantiomers production | |
HU221194B1 (en) | Ltb4 antagonist benzopyran derivatives, process for producing them, and pharmaceuticals containing them, and the use of them as ltb4 antagonist for medicaments | |
WO1997014670A1 (en) | Lignans, a process for their production and pharmaceutical compositions and uses thereof | |
EP0098713A2 (en) | Benzoylpiperazine esters and a process for their production | |
US4134991A (en) | Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid | |
JPH02306947A (ja) | キラルβ―アミノ酸の製造方法 | |
SU910118A3 (ru) | Способ получени N @ -глюкофуранозид-6-ил-N @ -нитрозомочевины | |
AU610379B2 (en) | New heteroarotinoid derivatives, processes for preparing them and pharmaceutical compositions containing them | |
US5252738A (en) | Process for the preparation of racemic and optically active 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid and its precursors | |
GB2036744A (en) | Eburnane derivatives | |
CH619468A5 (xx) | ||
WO2006029075A2 (en) | Fibrate compounds having ppar agonist activity | |
DK167018B1 (da) | 3-furylamino-1-benzazepiner samt fremgangsmaade til fremstillig deraf | |
EP0385423B1 (de) | Verfahren zur Herstellung der optischen Isomeren von 1,4-Dihydro-5-isopropoxy-2-methyl-4-(2-trifluormethylphenyl)-1,6-naphthyridin-3-carbonsäure-ethyl-ester und 1,4-Dihydro-5-isopropoxy-2-methyl-4-(2-trifluormethylphenyl)-1,6-naphthyridin-3-carbonsäure- 2-(N-methyl-N-phenylmethylamino)ethyl ester | |
HU182338B (en) | Process for producing bis-hydroxybenzyl derivatives and pharmaceutical compositions containing them | |
DK169100B1 (da) | (L)-Menthyl-2-oxo-4-phenylbutyrat samt fremgangsmåde til fremstilling og isolering af i det væsentlige ren (R)-2-hydroxy-4-phenylsmørsyre og estere deraf | |
SK568590A3 (en) | Glutaric acid derivatives and method for the preparation thereof, and intermediate product of said method | |
US2957877A (en) | New process for the preparation of organic alkaloid-like compounds | |
KR850000569B1 (ko) | 카르니틴의 아실-유도체 제조방법 | |
Brouillette et al. | Preparation of the Racemate and Enantiomers of 3-Hydroxy-5, 5-dimethylhexanoic Acid | |
CS208142B2 (cs) | Způsob výroby nových substituovaných benzocykloalkenylkarboxylových kyselin a popřípadě jejich esterů nebo amidů | |
JPH02149561A (ja) | 新規カテコール誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
IF00 | In force as of 2000-06-30 in czech republic | ||
MM4A | Patent lapsed due to non-payment of fee |
Effective date: 20050517 |